Finally, the ability of VHH1D12 to activate type 1 NKT cells (Figure S1E) and to block diverse NKT cells (which interact with a different epitope on CD1d, adopt an alternative docking mode over CD1d, and include pro-tumor sulfatide-reactive type 2 NKT cells22) was preserved. This evidence concerns the gene CD1D and neoplasm.